Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of a Single-dose Denosumab on Semen Quality in Infertile Men (FITMI): A Randomized Controlled Trial

NCT05212337 is registered in ClinicalTrials.gov with Martin Blomberg Jensen as lead sponsor.

NCT NCT05212337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05212337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of a Single-dose Denosumab on Semen Quality in Infertile Men (FITMI): A Randomized Controlled Trial
Lead sponsor
Martin Blomberg Jensen
Phase
Phase 2
Overall status
Active, not recruiting
Start date
January 1, 2022
Completion date
September 30, 2025
Enrollment
180 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility, male